Show simple item record

dc.contributor.authorOmwoyo, Wesley Nyaigoti
dc.contributor.authorOgutu, Bernhards
dc.contributor.authorOloo, Florence
dc.contributor.authorSwai, Hulda
dc.contributor.authorKalombo, Lonji
dc.contributor.authorMelariri, Paula
dc.contributor.authorMahanga, Geoffrey M.
dc.contributor.authorGathirwa, Jeremiah Waweru
dc.date.accessioned2018-11-20T12:00:54Z
dc.date.available2018-11-20T12:00:54Z
dc.date.issued2014-08-11
dc.identifier.uri10.2147/IJN.S62630
dc.identifier.urihttp://ir.jooust.ac.ke:8080/xmlui/handle/123456789/2908
dc.description.abstractPrimaquine (PQ) is one of the most widely used antimalarial drugs and is the only available drug that combats the relapsing form of malaria. PQ use in higher doses is limited by severe tissue toxicity including hematological- and gastrointestinal-related side effects. Nanoformulation of drugs in an appropriate drug carrier system has been extensively studied and shown to have the potential to improve bioavailability, thereby enhancing activity, reducing dose frequency, and subsequently reducing toxicity. The aim of this work was to design, synthesize, and characterize PQ-loaded solid lipid nanoparticles (SLNs) (PQ-SLNs) as a potential drug-delivery system. SLNs were prepared by a modified solvent emulsification evaporation method based on a water-in-oil-in-water (w/o/w) double emulsion. The mean particle size, zeta potential, drug loading, and encapsulation efficiency of the PQ-SLNs were 236 nm, +23 mV, 14%, and 75%, respectively. The zeta potential of the SLNs changed dramatically, from −6.54 mV to +23.0 mV, by binding positively charged chitosan as surface modifier. A spherical morphology of PQ-SLNs was seen by scanning electron microscope. In vitro, release profile depicted a steady drug release over 72 hours. Differential scanning calorimeter thermograms demonstrated presence of drug in drug-loaded nanoparticles along with disappearance of decomposition exotherms, suggesting increased physical stability of drug in prepared formulations. Negligible changes in characteristic peaks of drug in Fourier transform infrared spectra indicated absence of any interaction among the various components entrapped in the nanoparticle formulation. The nanoformulated PQ was 20% more effective as compared with conventional oral dose when tested in Plasmodium berghei-infected Swiss albino mice. This study demonstrated an efficient method of forming a nanomedicine delivery system for antimalarial drugs.en_US
dc.description.sponsorshipConsortium for National Health Research; National Commission for Science, Technology and Innovation; National Research Foundation South Africa;en_US
dc.language.isoenen_US
dc.publisherPMCen_US
dc.subjectdouble emulsionen_US
dc.subjectnanomedicine drug-delivery systemen_US
dc.subjectantimalarialen_US
dc.subjectnanotechnologyen_US
dc.titlePreparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticlesen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record